Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Monthly intravenous Mircera maintenance in haemodialysis patients with chronic renal anaemia
2007-005799-15Phase 3Completed
- Sponsor
- Roche
- Start
- May 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of Epoetin alfa RB in Uraemic Anaemia, sponsored by Roche. Primary endpoint: Proportion of patients maintaining average haemoglobin concentration during the EEP within the target range. Started May 2008; status: completed.
02
Drugs
Epoetin alfa RB
03
Conditions
Uraemic Anaemia
Beyond the preview
Go deeper on 2007-005799-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005799-15.